NNC 0113-0217
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for NNC 0113-0217, covering 2017-05-08 to 2017-05-08. Get the full timeline:
Most recent: Clinical Trial Update: Dose Escalation Trial of Single Subcutaneous Doses of NNC 0113-0217 to Assess Safety, Tolerability, Pharmacokinetics and Pharmacodynamics in Healthy Male Subjects [Phase 1]